C. Wu
Impact in
- Biotechnology top 2%
- Cancer Research and Treatments
-
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Cancer Research and Treatments 8
- Oncology 6
- Peptidase Inhibition and Analysis 3
- Cancer Immunotherapy and Biomarkers 1
- Co-authors
- Niramol Savaraj (9 shared papers)Lynn G. Feun (8 shared papers)M. Tien Kuo (4 shared papers)Medhi Wangpaichitr (6 shared papers)Min You (5 shared papers)S. Spector (2 shared papers)F. Moffat (2 shared papers)John S. Bomalaski (3 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Current Molecular Medicine (1 paper)Current Pharmaceutical Design (1 paper)British Journal of Cancer (1 paper)Journal of Hepatology (1 paper)
- Partner nations
- United StatesNetherlandsChina
In The Last Decade
C. Wu
11 papers receiving 426 citations
Peers
Comparison fields: 5 of 69
- Biotechnology 253
- Cancer Research 151
- Biochemistry 42
- Genetics 131
- Molecular Biology 187
Countries citing papers authored by C. Wu
This map shows the geographic impact of C. Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Wu more than expected).
Fields of papers citing papers by C. Wu
This network shows the impact of papers produced by C. Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Wu. The network helps show where C. Wu may publish in the future.
Co-authors
The 23 scholars most cited alongside C. Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 184 | |
| 2 | 2012 | 88 | |
| 3 | 2010 | 87 | |
| 4 | 2017 | 35 | |
| 5 | Relationship of multidrug resistance to rhodamine-123 selectivity between carcinoma and normal epithelial cells: taxol and vinblastine modulate drug efflux. | 1995 | 21 |
| 6 | 2010 | 8 | |
| 7 | 2006 | 6 | |
| 8 | 2016 | 2 | |
| 9 | 2008 | 2 | |
| 10 | 2012 | 1 | |
| 11 | 2011 | 1 |
About C. Wu
C. Wu is a scholar working on Biotechnology, Oncology, Genetics, Cancer Research and Molecular Biology, having authored 11 papers that have together received 435 indexed citations. Recurring topics across this work include Cancer Research and Treatments (8 papers), Virus-based gene therapy research (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Peptidase Inhibition and Analysis (3 papers), Polyamine Metabolism and Applications (2 papers), Cancer Immunotherapy and Biomarkers (1 paper), Pharmacological Effects and Toxicity Studies (1 paper) and Nanoplatforms for cancer theranostics (1 paper). The work is most often cited by research in Biotechnology (253 citations), Cancer Research (151 citations), Biochemistry (42 citations), Genetics (131 citations) and Molecular Biology (187 citations). C. Wu has collaborated with scholars based in United States, Netherlands and China. Frequent co-authors include Niramol Savaraj, Lynn G. Feun, M. Tien Kuo, Medhi Wangpaichitr, Min You, S. Spector, F. Moffat, John S. Bomalaski, George W. Elgart and Warren R. Sisson. Their work appears in journals such as Journal of Clinical Oncology, Current Molecular Medicine, Current Pharmaceutical Design, British Journal of Cancer and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.